OPTI.GB OptiBiotix Health plc

TIDMOPTI

RNS Number : 1089E

OptiBiotix Health PLC

09 March 2022

OptiBiotix Health plc

("OptiBiotix" or the "Company ")

Exercise of warrants

OptiBiotix Health p lc (AI M: OPTI), a life sciences busi ness d eveloping compou n ds to tackle obesity, high cholesterol, blood pressure, diabetes, ann o un ces that it has received notification to exercise warrants over 60 new ordinary shares of 2p each in the capital of the Company ("Ordinary Shares"). The exercise price of the warrants was 8p per share, providing the Company with proceeds of GBP4.80.

Application will be made for the 60 new Ordinary Shares to be admitted to trading on AIM, which is expected to occur at 8.00 a.m. on or around 14 March 2022. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares.

Total Voting Rights

For the purpose of the Disclosure and Transparency Rules, following the issue of shares detailed above the enlarged issued share capital of the Company will comprise 88,065,661 ordinary shares of 2p each. The Company does not hold any ordinary shares in treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

For further information, please contact:

 
 OptiBiotix Health plc                                   www.optibiotix.com 
 Stephen O'Hara, Chief Executive                 Contact via Walbrook below 
 
 
 Cairn Financial Advisers LLP (NOMAD)                    Tel: 020 7213 0880 
 Liam Murray / Jo Turner / Ludovico Lazzaretti 
 
 Cenkos Securities plc (Broker)                          Tel: 020 7397 8900 
 Callum Davidson / Neil McDonald 
 Michael Johnson / Russell Kerr (Sales) 
 
 Walbrook PR Ltd                                         Mob: 07407 804 654 
 Alice Woodings 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEZZGGFMRNGZZZ

(END) Dow Jones Newswires

March 09, 2022 02:00 ET (07:00 GMT)

OptiBiotix Health (AQSE:OPTI.GB)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024

OptiBiotix Health (AQSE:OPTI.GB)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024